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Case report

Lessons learned from delayed diagnosis in Acute
Intermittent Porphyria
Farn-Hsuan Tseng*, Gordon F Wadge, Stratton A Reichen, Caley McIntyre
Email: v-ftseng@ochsner.org

Abstract
A 56-year-old, previously healthy woman with a family history of acute intermittent porphyria (AIP) presenting
with altered mental status, severe abdominal pain and falls; who later developed seizures and new delusions
involving missing organs. Due to the nonspecific clinical presentation of AIP and low availability of diagnostic
tools, the diagnosis was delayed resulting in treatment delay. This case report hopes to raise AIP awareness
among clinicians, so better care can be delivered.
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Introduction
Acute Intermittent Porphyria (AIP), also known
as Swedish porphyria, is an uncommon, inherited
disorder of the heme synthesis pathway. It
usually presents with episodic, acute neurovisceral
attacks that can be life-threatening. The estimated
prevalence of acute attack is approximately 5
per 100,000.1 Diagnosis and management of
AIP has been a challenge due to its nonspecific
clinical manifestations, low clinical suspicion, and
unavailability of diagnostic tools as well as prompt
treatment. We report an adult female with a family
history of AIP who presented with several days
of altered mental status, severe abdominal pain,
and falls. In the hospital, she developed seizures,
hypertension and symptoms of acute psychosis.
AIP diagnosis was presumed later and supported by
laboratory findings.
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Case Presentation
A 56-year-old woman with a family history of
acute intermittent porphyria (AIP) presented to
an outside hospital with a 3-day history of altered
mental status, severe abdominal pain and falls.
In the Emergency Department, she developed
generalized tonic-clonic seizures and hypertensive
emergency, requiring intubation and Intensive Care
Unit admission. Her condition stabilized following
treatment with lorazepam, levetiracetam and
labetalol. A brain MRI without contrast showed
signs of chronic hypertensive microhaemorrhage
without acute intracranial abnormalities. An
abdominal ultrasound did not reveal significant
findings. On day 4, the patient was extubated and
transferred to our hospital for further evaluation due
to a suspicious for AIP.
On admission, the patient had retrograde amnaesia
and developed new delusions involving missing
organs. The neurological examinations showed no
focal deficits. No skin blisters were seen on exam. She
had abdominal pain which resolved with morphine.
Laboratory studies included complete blood count,
comprehensive metabolic panel, full toxicology
screen, TSH, RPR, vitamin B1, 2, 6, 12, D and E,
iron, HIV, prothrombin time and urinalysis, which
revealed normal results. No epileptic pattern was
seen on EEG. She refused lumbar puncture. Due to
suspicion of AIP, urine porphobilinogen (PBG) and
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plasma porphyrins were sent for laboratory testing.
The patient’s delusions and vital sign instability
resolved over the next three days, and the patient
was discharged on amlodipine, carvedilol, lisinopril
and levetiracetam with close follow-up.
One week following discharge, the results of
porphyrin testing were received. Random urine PBG
was 32.7 μmol/L (Normal range: 0.0-8.8 μmol/L).
The 24hour urine PBG was 67.9 μmol/d (Normal
range: 0.0-11.0 μmol/d). Plasma porphyrins were not
elevated. Fractionated urinary porphyrins showed
that uroporphyrin in 24-hour urine was 17μmol/
mol (Normal range: 0-4 μmol/mol), coproporphyrin
in 24-hour urine was 8 μmol/mol (Normal range:
0-6 μmol/mol) and coproporphyrin (CP) III was
145 μmol/mol (Normal range: 0-14 μmol/mol).
Attempts were made to contact the patient, but were
unsuccessful. It was later learned that the patient
was readmitted to another hospital for a suspected
repeat attack.
Discussion
AIP is an autosomal dominant, low penetrance
(~1%) disease resulting from mutation in the
hydroxymethylbilane synthase (HMBS) gene that
codes for porphobilinogen deaminase (PBGD)
protein in the heme synthesis pathway.2 Symptoms
may include abdominal pain, vomiting, constipation,
paresis, psychiatric symptoms, pain in limb,
head, neck, back or chest, respiratory paralysis,
hypertension, tachycardia and convulsion, and
are highly variable.3Associations with posterior
reversible encephalopathy syndrome (PRES),
hyponatraemia, and syndrome of inappropriate
antidiuretic hormone secretion (SIADH) are also
documented.4,5
Suspicion for AIP should be raised in a patient with
unexplained abdominal pain and/or neuropsychiatric
symptoms after ruling out more common causes.
Urinary PBG should be obtained; an increased
level is sufficient to initiate hemin to alleviate attack
severity. Carbohydrate loading is another treatment
option but is less effective and carries a potential
risk of fatal hyponatremia.6 Further testing for total
and fractionated urinary porphyrin, plasma and fecal
porphyria should be sent to differentiate between
AIP and other acute porphyrias. Confirmation of
the diagnosis is made by identifying decreased
erythrocyte PBGD and mutation in HMBS gene.1
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Diagnosis and management of AIP is clinically
challenging due to its nonspecific symptoms.
Because of its rarity, clinicians often have a low
initial suspicion for AIP. Diagnostic testing is not
widely available and may take weeks to know result.
Because of these challenges, prompt treatment
is often delayed. In patients with a known prior
diagnosis of AIP, treatment may be started based
on clinical diagnosis of an acute attack. In this case,
our diagnosis was limited by unavailability of timely
PBG results. Despite hemin therapy is indicated
in the setting of attacks of AIP, due to unclear
diagnosis and clinical improvement, it was not used
in this case. It is unclear whether earlier diagnosis
and prompt hemin treatment would have prevented
re-hospitalization in this patient.
Conclusion
AIP has a nonspecific presentations. Due to the low
clinical suspicion and the unavailability of diagnostic
tools, diagnosis in AIP is often delayed resulting in
treatment delay. Clinicians need to be aware of AIP
symptoms and initiate prompt management.
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